Explanation of Strategy

Business Conditions

Strengths and Strategies
ASKA Pharma Medical is using its highly sensitive measurement technology for endogenous hormones todevelop business in areas such as Femtech and healthcare.

ASKA Pharma MedicalStrengths• Unique high-sensitivity measurement technology using LC-MS/MS* (optimization of measurement conditions,

We will contribute to thecreation of a vibrant, healthysociety through our unique
technologies.

separation and purification technology, and derivatization)• Multi item simultaneous steroid hormone measurement• Ultra-sensitive estrogen measurement• Measurements using non-invasive samples* Liquid chromatography-tandem mass spectrometry

Strategies
ASKA Pharma Medical specializes in the testing andsignificantly to the efficient implementation of these

diagnostics business based on the corporate philosophy ofhealthcare programs. In particular, the technologies that“contributing to the creation of a vibrant, healthy societymeasure trace amounts from non-invasive, self-collectablethrough the latest measurement technologies.” Utilizing thesamples, such as hair, saliva, and fingernails, can lower theadvanced technologies and abundant know-how we havehurdle to testing. This, we believe, can contribute to higher

cultivated to date, we will contribute to a wide range ofscreening rates. At ASKA Pharma Medical, we arefields, including basic research, clinical research, andcommitted to using our strengths in high-sensitivity

diagnostics, with a focus on the measurement of steroid

measurement technology to help create a vibrant, healthy

hormones and other bioactive substances.

society for the future.

• Contract measurement of trace samples using high-sensitivity measurement technology (differentiation fromother companies)• Collaboration with related companies on high-sensitivity measurement technology• Development of Femtech-related businesses using ultra-sensitive estrogen measurement technology• Growth of the healthcare business through the development of a non-invasive measurement kit that enables
self-collection of samples

Recently, with the rapid aging of society, extending
healthy life expectancy has become an important issue.

Junichi Saito

Preventive medicine, improving pre-symptomatic states, andself-medication are attracting attention as approaches toPresident, Representative Director

solving this issue. We believe that our proprietary high-ASKA Pharma MedicalTOPICS

Utilization of Highly Sensitive Measurement Technology for
Endogenous Hormones

sensitivity measurement technology can contribute
ASKA Pharma Medical is using its strengths in highlyLtd. and collaborating with ASKA Pharmaceutical tosensitive measurement technology for endogenous

participate in Femtech-related businesses.

hormones to develop its healthcare business.

Main Products
Nail stress hormone level
test kit
Cortisol

Hair stress hormone level
test kit
Cortisol

Hair hormone levelmeasurement kit
Dihydrotestosterone

Hair hormone levelmeasurement kit
Testosterone

Going forward, we will continue striving to serve the needs

In the non-invasive testing business, which is based onof all end users. Creating test kits in a wide range of fields,

high-sensitivity steroid hormone measurement technology,

we will use open innovation to develop biomarkers that

we launched the “Hair hormone level measurement

contribute to better healthcare for all members of society.

kit—Dihydrotestosterone” in July 2021. The kit, whichtargets androgenetic alopecia, can measure hair hormone
levels using a sample of only 1 mg of hair. In FY2023, weare looking to grow this business by expanding test items
and increasing the types of samples that can be used (hair,saliva, and nails). In April 2023, we also launched the “Hairhormone measurement kit—Testosterone” that tests formale menopause. In July 2023, we launched the “Hair andnail stress hormone test kit—Cortisol” that tests for stress.
We are pursuing various initiatives for the future by
applying proprietary technologies through open innovation.
Among these, we are developing next-generation cancer
screening tests through a business alliance with MiRTeL Co.,

32

ASKA HD REPORT 2023

Measuring instrument LC-MS/MS

ASKA HD REPORT 2023

33